WO2023209441 - IMIDAZO[4,5-C]PYRIDINE DERIVATIVE COMPOUNDS AS TLR7/8 MODULATORS
National phase entry:
Publication Number
WO/2023/209441
Publication Date
02.11.2023
International Application No.
PCT/IB2023/000251
International Filing Date
01.05.2023
Title **
[English]
IMIDAZO[4,5-C]PYRIDINE DERIVATIVE COMPOUNDS AS TLR7/8 MODULATORS
[French]
COMPOSÉS DÉRIVÉS D'IMIDAZO[4,5-C]PYRIDINE EN TANT QUE MODULATEURS DE TLR7/8
Applicants **
LIGACHEM BIOSCIENCES INC.
Inventors
SONG, Ho, Young
CHAE, Sang, Eun
LEE, Won, Mi
BAEK, Juyuel
PARK, Kyung, Eun
PARK, Se, Yeon
PARK, Yun-Hee
KWON, Keon, Woo
BAE, Hyun, Joo
CHUNG, Chul-Woong
OH, Jihye
Priority Data
10-2022-0053658
29.04.2022
KR
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
MOIP
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 4699 | |
| EPO | Filing, Examination, Granting | 65938 | |
| Japan | Filing, Examination, Granting | 4087 | |
| South Korea | Filing, Examination, Granting | 4117 | |
| USA | Filing, Examination, Granting | 22990 |
Total:
101,831
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
Disclosed herein are immune response modulators that act on toll-like receptors and methods of use thereof.[French]
L'invention concerne des modulateurs de réponse immunitaire qui agissent sur des récepteurs de type toll et des méthodes d'utilisation de ceux-ci.